SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-016590
Filing Date
2019-08-23
Accepted
2019-08-23 16:03:27
Documents
2
Group Members
JONATHAN & NANCY GLASER FAMILY TRUST DTD 12/16/1998NANCY E. GLASERPACIFIC CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G sc13g0819a4glaser_jaguar.htm SC 13G/A 108532
2 JOINT FILING AGREEMENT sc13g0819a4ex99-1_jaguar.htm EX-99.1 11154
  Complete submission text file 0001213900-19-016590.txt   121184
Mailing Address 11601 WILSHIRE BLVD., SUITE 2180 LOS ANGELES CA 90025
Business Address
GLASER JONATHAN M (Filed by) CIK: 0001264694 (see all company filings)

Type: SC 13G/A

Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88872 | Film No.: 191049155
SIC: 2834 Pharmaceutical Preparations